STOCK TITAN

Upexi Inc Financials

UPXI
FY2025 annual
Revenue $15.8M -39.2% YoY
Net Income -$13.7M +42.2% YoY
EPS (Diluted) -$1.73 YoY not available
Free Cash Flow -$8.8M -752.2% YoY
Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE June

Upexi Inc (UPXI) reported $15.8M in revenue for fiscal year 2025, down 39.2% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI UPXI FY2025

FY2025 was defined by recapitalization and asset redeployment, while the core revenue base stayed too small to cover overhead.

What looks like deleveraging was really a balance-sheet recap: FY2025 brought $110.0M of financing inflow, yet cash ended at only $3.0M, so the capital was largely redeployed instead of sitting as operating liquidity.

The business still shows positive gross economics—gross margin reached 68.7%—but that did not translate into earnings because overhead outgrew the sales base, with SG&A absorbing about 75.5% of revenue. That pattern points to a cost structure sized for a larger company, which is why operating losses stayed deep even as product-level margin improved.

From FY2024 to FY2025, total assets jumped from $23.5M to $123.8M while operating cash outflow widened, so the company became far better capitalized without becoming more self-funding. That combination suggests the year changed where capital sits on the balance sheet more than it changed the earning power of the existing revenue stream.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 10 / 100
Financial Health Score 10/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Upexi Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
21
Dilution
4
R&D Intensity
0

Not available for Upexi Inc, and counted as zero in the overall score.

Revenue Progress
12
Burn Trend
0

Not available for Upexi Inc, and counted as zero in the overall score.

Balance Sheet
21
Altman Z-Score Distress
0.50

Upexi Inc scores 0.50, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($64.7M) relative to total liabilities ($33.7M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
4/8

Upexi Inc passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing
N/A

Upexi Inc reported a net loss of $13.7M while operations used $8.4M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Upexi Inc reported an operating loss of $12.5M against $104K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$15.8M
YoY-39.2%
5Y CAGR+16.4%

Upexi Inc generated $15.8M in revenue in fiscal year 2025. This represents a decrease of 39.2% from the prior year.

EBITDA
-$11.7M
YoY+37.5%

Upexi Inc's EBITDA was -$11.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 37.5% from the prior year.

Net Income
-$13.7M
YoY+42.2%

Upexi Inc reported -$13.7M in net income in fiscal year 2025. This represents an increase of 42.2% from the prior year.

EPS (Diluted)
-$1.73

Upexi Inc earned -$1.73 per diluted share (EPS) in fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow
-$8.8M
YoY-752.2%

Upexi Inc recorded an outflow of $8.8M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents a decrease of 752.2% from the prior year.

Cash & Debt
$3.0M
YoY+349.8%
5Y CAGR+27.4%

Upexi Inc held $3.0M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Shares Outstanding
38M

Upexi Inc had 38M shares outstanding in fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
68.7%
YoY+19.4pp
5Y CAGR+34.1pp

Upexi Inc's gross margin was 68.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 19.4 percentage points from the prior year.

Operating Margin
-79.1%
YoY+7.3pp
5Y CAGR-13.8pp

Upexi Inc's operating margin was -79.1% in fiscal year 2025, reflecting core business profitability. This is up 7.3 percentage points from the prior year.

Net Margin
-86.6%
YoY+4.4pp
5Y CAGR-13.9pp

Upexi Inc's net profit margin was -86.6% in fiscal year 2025, showing the share of revenue converted to profit. This is up 4.4 percentage points from the prior year.

Return on Equity
-15.2%
YoY+347.9pp
5Y CAGR+231.9pp

Upexi Inc's ROE was -15.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 347.9 percentage points from the prior year.

Capital Allocation

Capital Expenditures
$388K
YoY-58.4%
5Y CAGR-27.4%

Upexi Inc invested $388K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 58.4% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

Share Buybacks

Not reported for fiscal year 2025.

UPXI Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

UPXI annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20
Revenue$26.1M$15.8M-39.2%$26.0M-28.7%$36.4M+58.0%$23.1M-4.3%$24.1M+225.0%$7.4M
Cost of Revenue$3.4M$4.9M-62.5%$13.2M-14.6%$15.4M+88.2%$8.2M-32.8%$12.2M+151.8%$4.8M
Gross Profit$22.7M$10.9M-15.3%$12.8M-39.0%$21.0M+41.4%$14.9M+25.0%$11.9M+363.0%$2.6M
SG&A Expenses$26.1M$11.9M+76.3%$6.8M-1.5%$6.9M-24.8%$9.1M+41.9%$6.4M+6.7%$6.0M
Operating Income-$219.5M-$12.5M+44.4%-$22.5M-82.9%-$12.3M-89.3%-$6.5M-554.8%$1.4M+129.5%-$4.8M
Interest Expense$49K$104K+4.2%$100K+102.1%-$4.7M-12417.2%$38K+174.6%$14K-89.9%$138K
Income Tax$0$0+100.0%-$332K-110.9%$3.0M+488.2%$518K-59.6%$1.3M$0
Net Income-$228.4M-$13.7M+42.2%-$23.7M-35.3%-$17.5M-754.8%-$2.0M-168.7%$3.0M+155.3%-$5.4M
EPS (Diluted)-$1.73-$23.03-$18.94-$0.43$0.21+139.6%-$0.53

Not reported in any period shown, so not listed: R&D Expenses.

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

UPXI Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

UPXI annual balance sheet
MetricFY25FY24FY23FY22FY21FY20
Total Assets$123.8M+426.6%$23.5M-63.1%$63.8M+31.6%$48.5M+77.9%$27.3M+325.7%$6.4M
Current Assets$56.8M+397.2%$11.4M-62.0%$30.0M+75.9%$17.1M-6.7%$18.3M+590.4%$2.6M
Cash & Equivalents$3.0M+349.8%$661K-85.3%$4.5M-37.2%$7.1M-50.8%$14.5M+1537.6%$888K
Inventory$1.2M-19.5%$1.4M-70.2%$4.8M-58.4%$11.6M+451.7%$2.1M+44.6%$1.4M
Accounts Receivable$158K-74.0%$607K-46.1%$1.1M+19.7%$940K-26.4%$1.3M+673.7%$165K
Goodwill$849K0.0%$849K-70.6%$2.9M-37.9%$4.6M+92.4%$2.4M0.0%$2.4M
Total Liabilities$33.7M+98.3%$17.0M-52.7%$36.0M+82.5%$19.7M+226.4%$6.0M+43.0%$4.2M
Current Liabilities$32.6M+157.3%$12.7M-43.5%$22.4M+121.1%$10.1M+74.0%$5.8M+65.3%$3.5M
Long-Term DebtN/AN/A$27.7MN/AN/AN/A
Total Equity$90.1M+1282.7%$6.5M-76.6%$27.8M-3.3%$28.8M+35.7%$21.2M+873.6%$2.2M
Retained Earnings-$60.5M-29.2%-$46.9M-102.0%-$23.2M-270.0%-$6.3M-50.4%-$4.2M+41.3%-$7.1M

UPXI Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

UPXI annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20
Operating Cash Flow-$21.5M-$8.4M-8208.7%-$101K-150.0%$203K+212.1%-$181K-106.2%$2.9M+170.6%-$4.2M
Capital Expenditures$234K$388K-58.4%$933K-0.5%$938K-82.8%$5.5M+283.4%$1.4M-26.3%$1.9M
Free Cash Flow-$21.8M-$8.8M-752.2%-$1.0M-40.7%-$735K+87.0%-$5.6M-471.3%$1.5M+124.9%-$6.1M
Investing Cash Flow-$134.0M-$99.3M-2841.4%-$3.4M-31.1%-$2.6M+76.4%-$10.9M-751.2%-$1.3M+12.4%-$1.5M
Financing Cash Flow$158.8M$110.0M+31200.4%-$354K-24.0%-$285K-107.7%$3.7M-69.1%$12.0M+325.5%$2.8M

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

UPXI Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

UPXI annual financial ratios
MetricFY25FY24FY23FY22FY21FY20
Gross Margin68.7%+19.4pp49.3%-8.4pp57.7%-6.8pp64.5%+15.1pp49.4%+14.7pp34.7%
Operating Margin-79.1%+7.3pp-86.4%-52.7pp-33.7%-5.6pp-28.1%-34.1pp5.9%+71.2pp-65.3%
Net Margin-86.6%+4.4pp-91.0%-43.0pp-48.0%-39.1pp-8.9%-21.2pp12.4%+85.0pp-72.6%
Return on Equity-15.2%+347.9pp-363.1%-300.3pp-62.8%-55.7pp-7.1%-21.1pp14.0%+261.1pp-247.1%
Return on Assets-11.1%+89.6pp-100.6%-73.2pp-27.4%-23.2pp-4.2%-15.2pp10.9%+95.0pp-84.1%
Current Ratio1.74+0.8x0.90-0.4x1.34-0.3x1.68-1.5x3.14+2.4x0.75
Debt-to-Equity0.37-2.2x2.61+1.6x1.00+0.3x0.68+0.4x0.28-1.7x1.94
FCF Margin-55.7%-51.7pp-4.0%-2.0pp-2.0%+22.4pp-24.4%-30.7pp6.3%+88.5pp-82.2%

Similar Companies

Frequently Asked Questions

What is Upexi Inc's annual revenue?

Upexi Inc (UPXI) reported $15.8M in total revenue for fiscal year 2025. This represents a -39.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Upexi Inc's revenue growing?

Upexi Inc (UPXI) revenue declined by 39.2% year-over-year, from $26.0M to $15.8M in fiscal year 2025.

Is Upexi Inc profitable?

No, Upexi Inc (UPXI) reported a net income of -$13.7M in fiscal year 2025, with a net profit margin of -86.6%.

Upexi Inc (UPXI) reported diluted earnings per share of -$1.73 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Upexi Inc (UPXI) had EBITDA of -$11.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Upexi Inc (UPXI) had a gross margin of 68.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Upexi Inc (UPXI) had an operating margin of -79.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Upexi Inc (UPXI) had a net profit margin of -86.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Upexi Inc (UPXI) has a return on equity of -15.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Upexi Inc (UPXI) recorded an outflow of $8.8M in free cash flow during fiscal year 2025. This represents a -752.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Upexi Inc (UPXI) recorded an outflow of $8.4M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Upexi Inc (UPXI) had $123.8M in total assets as of fiscal year 2025, including both current and long-term assets.

Upexi Inc (UPXI) invested $388K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Upexi Inc (UPXI) had 38M shares outstanding as of fiscal year 2025.

Upexi Inc (UPXI) had a current ratio of 1.74 as of fiscal year 2025, which is generally considered healthy.

Upexi Inc (UPXI) had a debt-to-equity ratio of 0.37 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Upexi Inc (UPXI) had a return on assets of -11.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Upexi Inc (UPXI) had $3.0M in cash against an annual operating cash burn of $8.4M. This gives an estimated cash runway of approximately 4 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Upexi Inc (UPXI) has an Altman Z-Score of 0.50, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Upexi Inc (UPXI) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Upexi Inc (UPXI) reported a net loss of $13.7M while operations used $8.4M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Upexi Inc (UPXI) reported an operating loss of $12.5M against $104K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Upexi Inc (UPXI) scores 10 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top